Manulife (Manufacturers Life Insurance)
NVLN

Manulife (Manufacturers Life Insurance)’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,845
Closed -$9K – 4409
2017
Q4 		$9K Buy
+2,845
New +$13.7K ﹤0.01% 4024
2017
Q3 		– Sell
-14,179
Closed -$130K – 4417
2017
Q2 		$130K Buy
14,179
+14,006
+8,096% +$135K ﹤0.01% 3280
2017
Q1 		$2K Hold
173
– – ﹤0.01% 3982
2016
Q4 		$1K Buy
+173
New +$1.53K ﹤0.01% 4288

Other funds holding NVLN

EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s NVLN Position: Q1 2018 in Review

Manulife (Manufacturers Life Insurance) sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q1 2018, closing a stake of 2,845 shares — an estimated $9K sold.

Manulife (Manufacturers Life Insurance) first reported a position in NVLN in Q4 2016 and held it in 4 quarters. The position peaked at $130K in Q2 2017. 68 funds tracked by Wall St. Rank hold NVLN as of Q1 2018.

  • Manulife (Manufacturers Life Insurance) reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q1 2018 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 2,845 Novelion Therapeutics Inc. Common Shares shares in Q1 2018, an estimated $9K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Novelion Therapeutics Inc. Common Shares in Q4 2016 and held it in 4 quarters.
  • Manulife (Manufacturers Life Insurance)'s Novelion Therapeutics Inc. Common Shares position peaked at $130K in Q2 2017.
  • 68 funds tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q1 2018.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2018, filed 15 May 2018.